Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors-Reference-Cited by-同舟云学术

Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors

Published:2019-05 Issue:5 Volume:25 Page:e163-e168
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Schoettler Michelle^ORCID,Lehmann Leslie,Li Anran,Ma Clement,Duncan Christine

Funder

NIH T32

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference20 articles.

1. Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT;Laskin;Bone Marrow Transplant,2011

2. High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma;Jodele;Bone Marrow Transplant,2018

3. Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy;Peffault de Latour;Br J Haematol,2013

4. Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver;Daly;Transfus Apher Sci,2002

5. Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children;Hale;Biol Blood Marrow Transplant,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pathology of Pulmonary Disease After Pediatric Hematopoietic Stem Cell Transplantation;American Journal of Surgical Pathology;2024-07-29

2. Hemostasis and complement in allogeneic hematopoietic stem cell transplantation: clinical significance of two interactive systems;Bone Marrow Transplantation;2024-07-14

3. Transplant-associated thrombotic microangiopathy in pediatrics: incidence, risk factors, therapeutic options, and outcome based on data from a single center;Frontiers in Oncology;2024-07-10

4. Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience;Bone Marrow Transplantation;2024-05-21

5. D‐dimer and sinusoidal obstructive syndrome‐novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study;American Journal of Hematology;2024-01-02